Unknown

Dataset Information

Antiamoebic drugs for treating amoebic colitis.


ABSTRACT:

Background

Infection with the protozoan Entamoeba histolytica is common in low- and middle-income countries, and up to 100,000 people with severe disease die every year. Adequate therapy for amoebic colitis is necessary to reduce illness, prevent development of complicated disease and extraintestinal spread, and decrease transmission.

Objectives

To evaluate antiamoebic drugs for treating amoebic colitis.

Search methods

We searched the available literature up to 22 March 2018. We searched the Cochrane Infectious Diseases Group Specialised Register, CENTRAL, MEDLINE, Embase, LILACS, mRCT, and conference proceedings. We contacted individual researchers, organizations, and pharmaceutical companies, and we checked reference lists.

Selection criteria

Randomized contr

SUBMITTER: Gonzales MLM 

PROVIDER: S-EPMC6326239 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature